Mammography Systems Market by Type (Analog Mammography Systems, Digital Mammography Systems, and Breast Tomosynthesis Systems), Technology (2-D Mammography, 3-D Mammography, and Combined 2-D and 3-D Mammography), and End-User (Inpatient Settings and Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2014-2022Mammography is a technique used for obtaining high resolution images of breast tissues. It helps in the detection of breast cancer and other breast-related disorders at the initial stages. The technique is an important aspect of breast cancer diagnosis, as breast cancer is one of the leading causes of death among women.
The global mammography systems market generated $1,534 million in 2015, and is projected to reach $2,648 million by 2022, registering a CAGR of 8.0% during the study period. In terms of volume, the global mammography systems market was 6,316 units in 2015 and is anticipated to reach 12,688 units by 2022, growing at a CAGR of 10.5%. This market is expected to witness significant growth during the forecast period due to increase in incidence of breast cancer, rise in geriatric population, and proactive initiatives by healthcare organizations to raise awareness about early detection of breast cancer. In addition, better reimbursement insurance policies, increased government funding for breast cancer research, and technological advancements, such as the breast tomosynthesis, which helps in easy detection of breast cancer in women with dense breast tissues fuel the demand for mammography systems. However, radiation exposure risks and generation of false positive or negative hamper the market growth.
The mammography systems market is segmented based on product type, technology, and region. Based on product type, the market is divided into analog mammography systems, digital mammography systems, and breast tomosynthesis systems. Digital mammography is sub-segmented into computed radiography and digital radiography. On the basis of technology, mammography market is segmented into 2D mammography, 3D mammography, and combined 2D and 3D mammography. The market is analyzed across four geographical regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
Prominent players adopted product development, including product launches and approvals, as their key developmental strategy for expanding their product portfolio. For instance, in April 2016, PLANMED OY received CE approval for the commercial distribution of its product, Planmed Clarity 3D digital breast tomosynthesis system and the Planmed Clarity 2D full field digital mammography system in Europe.
Moreover, reimbursement for mammography systems, such as digital mammography systems, have fueled the demand for breast imaging in the recent years. For instance, Medicare provides Part B coverage of screening mammography for women.
This report provides an extensive analysis of the current and emerging market trends and dynamics in the global mammography systems market.
Comprehensive analysis of geographical regions is provided to determine the prevailing opportunities in the global market.
This study provides the competitive landscape of the global market to predict the competitive environment across geographies.
This report entails the detailed quantitative analysis of the current market and estimations from 2014 to 2022 to identify the prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
Region- and country-wise mammography systems market conditions are comprehensively analyzed in the report to understand the regional trends and dynamics.
Mammography Systems Market key Segments
Analog Mammography Systems
Digital Mammography Systems
Computed Radiography Systems
Digital Radiography Systems
Breast Tomosynthesis Systems
Combined 2D and 3D Mammography
Ambulatory Surgical Centers
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA
1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. RESEARCH METHODOLOGY
1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools and models
CHAPTER 2. EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3. MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. MARKET DYNAMICS
188.8.131.52. Growing breast cancer prevalence
184.108.40.206. Rising geriatric population
220.127.116.11. Government funding for breast cancer treatment and related research
18.104.22.168. Technological advancements
22.214.171.124. Increasing awareness for breast cancer
126.96.36.199. Radiation risks
188.8.131.52. Inaccurate results
184.108.40.206. Combination of 2D and 3D mammography
220.127.116.11. Emerging Markets
3.3.4. Impact analysis
3.4.1. Introduction of CAD systems for mammography
3.4.2. Shift towards digital mammography and tomosynthesis
3.5. MARKET SHARE ANALYSIS, 2015
3.7. GOVERNMENT RECOMMENDATIONS
3.8. GOVERNMENT REGULATIONS
CHAPTER 4. GLOBAL MAMMOGRAPHY SYSTEMS MARKET, BY PRODUCT
4.1.1. Key market trends
4.1.2. Growth factors and opportunities
4.1.3. Market size and forecast
4.1.4. Analog Mammography Systems
18.104.22.168. Market size and forecast
4.1.5. Digital Mammography Systems
22.214.171.124. Market size and forecast
126.96.36.199. Computed radiography (CR) mammography systems
188.8.131.52. Market size and forecast
184.108.40.206. Digital radiography (DR) mammography systems
220.127.116.11. Market size and forecast
4.1.6. Breast Tomosynthesis
18.104.22.168. Market size and forecast
CHAPTER 5. GLOBAL MAMMOGRAPHY SYSTEMS MARKET, BY TECHNOLOGY
5.1.1. Market size and forecast
5.2. 2-D TECHNOLOGY
5.2.1. Market size and forecast
5.3. 3-D TECHNOLOGY
5.3.1. Market size and forecast
5.4. COMBINED 2-D AND 3-D TECHNOLOGY
5.4.1. Market size and forecast
CHAPTER 6. MAMMOGRAPHY MARKET, BY END USER
6.1.1. Market size and forecast
6.2. INPATIENT SETTINGS
6.2.1. Market size and forecast
6.3. AMBULATORY SURGICAL CENTERS (ASCS)
6.3.1. Market size and forecast
CHAPTER 7. GLOBAL MAMMOGRAPHY SYSTEMS MARKET, BY REGION
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast
7.3.1. Key market trends
7.3.2. Growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany market size and forecast
7.3.5. France market size and forecast
7.3.6. UK market size and forecast
7.3.7. Italy market size and forecast
7.3.8. Spain market size and forecast
7.3.9. Rest of Europe market size and forecast
7.4.1. Key market trends
7.4.2. Growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan market size and forecast
7.4.5. China market size and forecast
7.4.6. India market size and forecast
7.4.7. Rest of Asia-Pacific market size and forecast
7.5.1. Key market trends
7.5.2. Growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil market size and forecast
7.5.5. South Africa market size and forecast
7.5.6. Kingdom of Saudi Arabia market size and forecast
7.5.7. Rest of LAMEA market size and forecast
CHAPTER 8. COMPANYPROFILES
8.1. ANALOGIC CORPORATION
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.1.6. Strategy share (%)
8.2. CARESTREAM HEALTH
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments
8.2.6. Strategy share (%)
8.3. FUJIFILM HOLDINGS CORPORATION
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.3.6. Strategy share (%)
8.4. GENERAL ELECTRIC COMPANY
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments
8.4.6. Strategy share (%)
8.5. HOLOGIC, INC.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. Key strategic moves and developments
8.5.6. Strategy share (%)
8.6. KONICA MINOLTA, INC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments
8.6.6. Strategy share (%)
8.7. KONINKLIJKE PHILIPS N.V.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Key strategic moves and developments
8.7.6. Strategy share (%)
8.8. PLANMED OY
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments
8.8.6. Strategy share (%)
8.9. SIEMENS AG
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments
8.9.6. Strategy share (%)
8.10. TOSHIBA MEDICAL SYSTEMS CORPORATION
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Business performance
8.10.5. Key strategic moves and developments
8.10.6. Strategy share (%)
Mammography systems help in the detection of breast cancer at initial stages. The market has witnessed significant growth in the recent past due to the increase in government funding to support R&D for breast cancer.
Advent of technologically advanced systems such as breast tomosynthesis and rise in incidence of breast cancer majorly drive the market growth. In addition, rise in geriatric population and proactive initiatives taken by healthcare organizations to raise awareness about early detection of breast cancer are anticipated to further drive the demand for mammography systems globally. However, radiation exposure risks and generation of false positive or negative restrict the market growth.
Digital mammography systems are expected to dominate the market throughout the analysis period, owing to the presence of advanced features such as image size, brightness, and contrast which helps determine the precise location and extent of cancer using a computer screen.
Based on technology, 2D mammography generated maximum revenue, accounting for almost four-fifths of the global mammography systems market in 2015. However, combined 2D and 3D technology segment is estimated to exhibit the highest growth rate of 14.7% during the forecast period.
Considering the end-user segment, inpatient settings generated the highest revenue accounting for more than half of the global mammography systems market. On the other hand, ambulatory surgery centers segment is poised to grow at the highest CAGR of 9.0% during the forecast period.
Key Findings of Mammography Systems Market
Breast tomosynthesis systems segment is projected to grow at a CAGR of 9.9% during the forecast period.
In terms of volume, digital mammography systems accounted for more than three-fourth share of the global mammography systems market.
3D mammography segment is expected to grow at a significant CAGR of 9.6%, owing to their ability to detect cancer in women with dense breast tissues.
France and Germany jointly contributed for nearly one-third of the European mammography systems market in 2015.
Japan is the major shareholder, accounting for almost half of the Asia-Pacific mammography systems market in 2015.
Asia-Pacific is projected to grow at the highest CAGR of 9.0% during the forecast period owing to improvement in healthcare infrastructures and rise in expenditures in emerging markets (such as India and China) to overcome the unmet medical needs. Technological advancements to develop cost-effective devices in these nations offer a lucrative opportunity for market growth.
The major companies profiled in the report include Analogic Corporation, Carestream Health, Fujifilm Holdings Corporation, General Electric Company, Hologic, Inc., Konica Minolta, Inc., Koninklijke Philips N.V., PLANMED OY, Siemens AG, and Toshiba Medical Systems Corporation.
- Analogic Corporation
- Carestream Health
- Fujifilm Holdings Corporation
- General Electric Company
- Hologic, Inc.
- Konica Minolta, Inc.
- Koninklijke Philips N.V.
- PLANMED OY
- Siemens AG
- Toshiba Medical Systems Corporation
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.